Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020250
Company: GLAXOSMITHKLINE

Products on NDA 20250

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
HALFAN	HALOFANTRINE HYDROCHLORIDE	250MG	TABLET;ORAL	Discontinued	None	No	No

Labels for NDA 020250

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/01/2002	SUPPL-8	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20250s7s8lbl.pdf
08/01/2002	SUPPL-7	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20250s7s8lbl.pdf